Exact Mass: 393.14369740000006
Exact Mass Matches: 393.14369740000006
Found 500 metabolites which its exact mass value is equals to given mass value 393.14369740000006
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
amsacrine
C21H19N3O3S (393.11470640000005)
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D007364 - Intercalating Agents L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents D000970 - Antineoplastic Agents
Dihydromacarpine
C22H19NO6 (393.12123140000006)
A benzophenanthridine alkaloid that is dihydrosanguinarine bearing two methoxy substituents.
Tifluadom
C22H20FN3OS (393.13110420000004)
C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D045283 - Natriuretic Agents > D004232 - Diuretics Same as: D02694
Fruquintinib
C21H19N3O5 (393.13246440000006)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C93259 - VEGFR Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163953 - VEGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
(S)-N1-(2-(tert-butyl)-4-methyl-[4,5-bithiazol]-2-yl)pyrrolidine-1,2-dicarboxamide
gamma-L-Glutamyl-S-(2-carboxy-1-propyl)cysteinylglycine
C14H23N3O8S (393.12057980000003)
gamma-L-Glutamyl-S-(2-carboxy-1-propyl)cysteinylglycine is found in onion-family vegetables. gamma-L-Glutamyl-S-(2-carboxy-1-propyl)cysteinylglycine is a constituent of onion (Allium cepa) and garlic (Allium sativum) Constituent of onion (Allium cepa) and garlic (Allium sativum). gamma-L-Glutamyl-S-(2-carboxy-1-propyl)cysteinylglycine is found in garden onion, garlic, and onion-family vegetables.
Amsacrine
C21H19N3O3S (393.11470640000005)
Aminoacridine derivative that is a potent intercalating antineoplastic agent. It is effective in the treatment of acute leukemias and malignant lymphomas, but has poor activity in the treatment of solid tumors. It is frequently used in combination with other antineoplastic agents in chemotherapy protocols. It produces consistent but acceptable myelosuppression and cardiotoxic effects. [PubChem] C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D007364 - Intercalating Agents L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents D000970 - Antineoplastic Agents
(gamma-Glutamyl-gamma-glutamyl)-S-methylcysteine
C14H23N3O8S (393.12057980000003)
(gamma-Glutamyl-gamma-glutamyl)-S-methylcysteine is found in pulses. (gamma-Glutamyl-gamma-glutamyl)-S-methylcysteine is a constituent of the seeds of Vigna radiata (mung bean). Constituent of the seeds of Vigna radiata (mung bean). (gamma-Glutamyl-gamma-glutamyl)-S-methylcysteine is found in pulses.
Erlotinib
C22H23N3O4 (393.16884780000004)
Erlotinib hydrochloride (trade name Tarceva, Genentech/OSIP, originally coded as OSI-774) is a drug used to treat non-small cell lung cancer, pancreatic cancer and several other types of cancer. Similar to gefitinib, erlotinib specifically targets the epidermal growth factor receptor (EGFR) tyrosine kinase. It binds in a reversible fashion to the adenosine triphosphate (ATP) binding site of the receptor. Erlotinib has recently been shown to be a potent inhibitor of JAK2V617F activity. JAK2V617F is a mutant of tyrosine kinase JAK2, is found in most patients with polycythemia vera (PV) and a substantial proportion of patients with idiopathic myelofibrosis or essential thrombocythemia. The study suggests that erlotinib may be used for treatment of JAK2V617F-positive PV and other myeloproliferative disorders. L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EB - Epidermal growth factor receptor (egfr) tyrosine kinase inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents
6'-Apiosyllotaustralin
C16H27NO10 (393.16348819999996)
6-Apiosyllotaustralin is found in root vegetables. 6-Apiosyllotaustralin is a constituent of the roots of Manihot esculenta (cassava). Constituent of the roots of Manihot esculenta (cassava). 6-Apiosyllotaustralin is found in root vegetables.
Epoxyfumitremorgin C
C22H23N3O4 (393.16884780000004)
Epoxyfumitremorgin C is from Aspergillus fumigatus. From Aspergillus fumigatus
Besifloxacin
C19H21ClFN3O3 (393.12553980000007)
N-Hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](3-picolyl)amino]-3-methylbutanamide hydrochloride
C18H23N3O5S (393.13583480000005)
Daprodustat
B - Blood and blood forming organs > B03 - Antianemic preparations C78275 - Agent Affecting Blood or Body Fluid Daprodustat (GSK1278863) is an orally active hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor being developed for the treatment of anemia associated with chronic kidney disease.
gamma-Glutamylfelinylglycine
1H-Indole-3-carboxylic acid, 1-methyl-, (1-(2-((methylsulfonyl)amino)ethyl)-4-piperidinyl)methyl ester
C19H27N3O4S (393.17221820000003)
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists GR 113808 is a potent and highly selective 5-HT4?receptor antagonist (pKb= 8.8). GR 113808 shows 300-fold selectivity over 5-HT1A, 5-HT1B, 5-HT2A, 5-HT2C and 5-HT3 receptors[1].
Q-100035
1-[5-(2-Cyclopropyl-5,7-dimethylimidazo[4,5-b]pyridin-3-ylmethyl)thiophen-2-yl]cyclopent-3-ene carboxylic acid
4-(2-Aminoethylamino)-3-[bis(carboxymethyl)amino]-3-(carboxymethyl)hexanedioic acid
Rubitecan
Rubitecan is a pyranoindolizinoquinoline that is camptothecin in which the hydrogen at position 9 has been replaced by a nitro group. It is a prodrug for 9-aminocamptothecin. It has a role as an antineoplastic agent, an EC 5.99.1.2 (DNA topoisomerase) inhibitor and a prodrug. It is a pyranoindolizinoquinoline, a C-nitro compound, a semisynthetic derivative, a tertiary alcohol and a delta-lactone. Rubitecan is a semisynthetic agent related to camptothecin with potent antitumor and antiviral properties. Rubitecan binds to and inhibits the enzyme topoisomerase I and induces protein-linked DNA single-strand breaks, thereby blocking DNA and RNA synthesis in dividing cells; this agent also prevents repair of reversible single-strand DNA breaks. (NCI04) C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059004 - Topoisomerase I Inhibitors C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor D004791 - Enzyme Inhibitors Rubitecan (RFS 2000), a Camptothecin derivative, is an orally active topoisomerase I inhibitor with broad antitumor activity, and induces protein-linked DNA single-strand breaks, thereby blocking DNA and RNA synthesis in dividing cells[1][2][3].
6-methoxyspirotryprostatin B
C22H23N3O4 (393.16884780000004)
An indole alkaloid isolated from a marine-derived fungal strain Aspergillus sydowii PFW1-13 and has been shown to exhibit cytotoxic activity.
Pirenperone
D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent Pirenperone (R 47465) is a 5-HT2 serotonin receptor antagonist. Pirenperone exhibits modest anxiolytic activity[1][2].
2-((6-O-(beta-D-apiofuranosyl)-beta-D-glucopyranosyl)oxy)-2-methylbutanenitrile
C16H27NO10 (393.16348819999996)
6-(1-hydroxyethyl)-5,6-dihydrochelerythrine
C23H23NO5 (393.15761480000003)
6-(1-Hydroxyethyl)-5,6-dihydrochelerythrine
C23H23NO5 (393.15761480000003)
AMG-073 HCl (Cinacalcet hydrochloride)
C22H23ClF3N (393.14710240000005)
S-(2-Carboxypropyl)glutathione
C14H23N3O8S (393.12057980000003)
Annotation level-3
Glutamyl-S-(C4H7O2)-cysteinylglycine
C14H23N3O8S (393.12057980000003)
Annotation level-3
Ala Cys Asn Ser
C13H23N5O7S (393.13181280000003)
Ala Cys Ser Asn
C13H23N5O7S (393.13181280000003)
Ala Asn Cys Ser
C13H23N5O7S (393.13181280000003)
Ala Asn Ser Cys
C13H23N5O7S (393.13181280000003)
Ala Ser Cys Asn
C13H23N5O7S (393.13181280000003)
Ala Ser Asn Cys
C13H23N5O7S (393.13181280000003)
Cys Ala Asn Ser
C13H23N5O7S (393.13181280000003)
Cys Ala Ser Asn
C13H23N5O7S (393.13181280000003)
Cys Gly Lys Ser
Cys Gly Asn Thr
C13H23N5O7S (393.13181280000003)
Cys Gly Gln Ser
C13H23N5O7S (393.13181280000003)
Cys Gly Ser Lys
Cys Gly Ser Gln
C13H23N5O7S (393.13181280000003)
Cys Gly Thr Asn
C13H23N5O7S (393.13181280000003)
Cys Lys Gly Ser
Cys Lys Ser Gly
Cys Asn Ala Ser
C13H23N5O7S (393.13181280000003)
Cys Asn Gly Thr
C13H23N5O7S (393.13181280000003)
Cys Asn Ser Ala
C13H23N5O7S (393.13181280000003)
Cys Asn Thr Gly
C13H23N5O7S (393.13181280000003)
Cys Gln Gly Ser
C13H23N5O7S (393.13181280000003)
Cys Gln Ser Gly
C13H23N5O7S (393.13181280000003)
Cys Ser Ala Asn
C13H23N5O7S (393.13181280000003)
Cys Ser Gly Lys
Cys Ser Gly Gln
C13H23N5O7S (393.13181280000003)
Cys Ser Lys Gly
Cys Ser Asn Ala
C13H23N5O7S (393.13181280000003)
Cys Ser Gln Gly
C13H23N5O7S (393.13181280000003)
Cys Thr Gly Asn
C13H23N5O7S (393.13181280000003)
Cys Thr Asn Gly
C13H23N5O7S (393.13181280000003)
Phe Gly Gly Asn
Phe Gly Asn Gly
Phe Asn Gly Gly
Gly Cys Lys Ser
Gly Cys Asn Thr
C13H23N5O7S (393.13181280000003)
Gly Cys Gln Ser
C13H23N5O7S (393.13181280000003)
Gly Cys Ser Lys
Gly Cys Ser Gln
C13H23N5O7S (393.13181280000003)
Gly Cys Thr Asn
C13H23N5O7S (393.13181280000003)
Gly Phe Gly Asn
Gly Phe Asn Gly
Gly Gly Phe Asn
Gly Gly Asn Phe
Gly Lys Cys Ser
Gly Lys Ser Cys
Gly Asn Cys Thr
C13H23N5O7S (393.13181280000003)
Gly Asn Phe Gly
Gly Asn Gly Phe
Gly Asn Thr Cys
C13H23N5O7S (393.13181280000003)
Gly Gln Cys Ser
C13H23N5O7S (393.13181280000003)
Gly Gln Ser Cys
C13H23N5O7S (393.13181280000003)
Gly Ser Cys Lys
Gly Ser Cys Gln
C13H23N5O7S (393.13181280000003)
Gly Ser Lys Cys
Gly Ser Gln Cys
C13H23N5O7S (393.13181280000003)
Gly Thr Cys Asn
C13H23N5O7S (393.13181280000003)
Gly Thr Asn Cys
C13H23N5O7S (393.13181280000003)
Lys Cys Gly Ser
Lys Cys Ser Gly
Lys Gly Cys Ser
Lys Gly Ser Cys
Lys Ser Cys Gly
Lys Ser Gly Cys
Asn Ala Cys Ser
C13H23N5O7S (393.13181280000003)
Asn Ala Ser Cys
C13H23N5O7S (393.13181280000003)
Asn Cys Ala Ser
C13H23N5O7S (393.13181280000003)
Asn Cys Gly Thr
C13H23N5O7S (393.13181280000003)
Asn Cys Ser Ala
C13H23N5O7S (393.13181280000003)
Asn Cys Thr Gly
C13H23N5O7S (393.13181280000003)
Asn Phe Gly Gly
Asn Gly Cys Thr
C13H23N5O7S (393.13181280000003)
Asn Gly Phe Gly
Asn Gly Gly Phe
Asn Gly Thr Cys
C13H23N5O7S (393.13181280000003)
Asn Ser Ala Cys
C13H23N5O7S (393.13181280000003)
Asn Ser Cys Ala
C13H23N5O7S (393.13181280000003)
Asn Ser Ser Ser
Asn Thr Cys Gly
C13H23N5O7S (393.13181280000003)
Asn Thr Gly Cys
C13H23N5O7S (393.13181280000003)
Gln Cys Gly Ser
C13H23N5O7S (393.13181280000003)
Gln Cys Ser Gly
C13H23N5O7S (393.13181280000003)
Gln Gly Cys Ser
C13H23N5O7S (393.13181280000003)
Gln Gly Ser Cys
C13H23N5O7S (393.13181280000003)
Gln Ser Cys Gly
C13H23N5O7S (393.13181280000003)
Gln Ser Gly Cys
C13H23N5O7S (393.13181280000003)
Ser Ala Cys Asn
C13H23N5O7S (393.13181280000003)
Ser Ala Asn Cys
C13H23N5O7S (393.13181280000003)
Ser Cys Ala Asn
C13H23N5O7S (393.13181280000003)
Ser Cys Gly Lys
Ser Cys Gly Gln
C13H23N5O7S (393.13181280000003)
Ser Cys Lys Gly
Ser Cys Asn Ala
C13H23N5O7S (393.13181280000003)
Ser Cys Gln Gly
C13H23N5O7S (393.13181280000003)
Ser Gly Cys Lys
Ser Gly Cys Gln
C13H23N5O7S (393.13181280000003)
Ser Gly Lys Cys
Ser Gly Gln Cys
C13H23N5O7S (393.13181280000003)
Ser Lys Cys Gly
Ser Lys Gly Cys
Ser Asn Ala Cys
C13H23N5O7S (393.13181280000003)
Ser Asn Cys Ala
C13H23N5O7S (393.13181280000003)
Ser Asn Ser Ser
Ser Gln Cys Gly
C13H23N5O7S (393.13181280000003)
Ser Gln Gly Cys
C13H23N5O7S (393.13181280000003)
Ser Ser Asn Ser
Ser Ser Ser Asn
Thr Cys Gly Asn
C13H23N5O7S (393.13181280000003)
Thr Cys Asn Gly
C13H23N5O7S (393.13181280000003)
Thr Gly Cys Asn
C13H23N5O7S (393.13181280000003)
Thr Gly Asn Cys
C13H23N5O7S (393.13181280000003)
Thr Asn Cys Gly
C13H23N5O7S (393.13181280000003)
Thr Asn Gly Cys
C13H23N5O7S (393.13181280000003)
Pentetic acid
D064449 - Sequestering Agents > D002614 - Chelating Agents > D007502 - Iron Chelating Agents D020011 - Protective Agents > D000931 - Antidotes
Tarceva
C22H23N3O4 (393.16884780000004)
gamma-L-Glutamyl-S-(2-carboxy-1-propyl)cysteinylglycine
C14H23N3O8S (393.12057980000003)
6'-Apiosyllotaustralin
C16H27NO10 (393.16348819999996)
Epoxyfumitremorgin C
C22H23N3O4 (393.16884780000004)
(g-Glutamyl-g-glutamyl)-S-methylcysteine
C14H23N3O8S (393.12057980000003)
ascr#8
C20H27NO7 (393.17874320000004)
A carboxamide resulting from the formal condensation of the carboxy group of ascr#7 with the amino group of 4-aminobenzoic acid. A metabolite of the nematode Caenorhabditis elegans, it is dauer inducing and strongly male attracting.
(2S)-2-acetamido-N-[(2S)-1-[[(2S)-1-(4-nitroanilino)-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]propanamide
2,3,5-Tri-O-acetyladenosine
2’,3’,5’-Tri-O-acetyl adenosine is an adenosine analog. Adenosine analogs mostly act as smooth muscle vasodilators and have also been shown to inhibit cancer progression. Its popular products are adenosine phosphate, Acadesine (HY-13417), Clofarabine (HY-A0005), Fludarabine phosphate (HY-B0028) and Vidarabine (HY-B0277)[1].
7-FLUORO-3,4-DIHYDRO-4-[(5-ISOQUINOLINYLOXY)ACETYL]-1,3,3-TRIMETHYL-2(1H)-QUINOXALINONE
C22H20FN3O3 (393.14886220000005)
Urea, N-[(2-chloro-6,8-dimethyl-3-quinolinyl)methyl]-N-(2-methylphenyl)-N-2-propenyl- (9CI)
2,6-BIS((3AS,8AR)-8,8A-DIHYDRO-3AH-INDENO[1,2-D]OXAZOL-2-YL)PYRIDINE
Benzyl 4-(benzyloxy)-5-methoxy-2-nitrobenzoate
C22H19NO6 (393.12123140000006)
Cinacalcet hydrochloride
C22H23ClF3N (393.14710240000005)
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D057966 - Calcimimetic Agents C78275 - Agent Affecting Blood or Body Fluid > C2136 - Malignancy-Associated Hypercalcemia Inhibitor D000077264 - Calcium-Regulating Hormones and Agents
21-Amino-17-hydroxypregna-1,4-diene-3,11,20-trione hydrochloride
C21H28ClNO4 (393.1706758000001)
5-(6-(BENZYLOXY)NAPHTHALEN-2-YL)-2,2-DIMETHYL-5-NITRO-1,3-DIOXANE
C23H23NO5 (393.15761480000003)
4-Cyanophenyl 4-(6-acryloyloxyhexyloxy)benzoate
C23H23NO5 (393.15761480000003)
methyl 2-[(3-cyanobenzoyl)amino]-3-(3-methoxypropyl)imidazo[4,5-b]pyridine-6-carboxylate
C20H19N5O4 (393.14369740000006)
1-(3,5-DIMETHYL-4-ETHYL-PYRROL-2-YL)-3-(3,5-DIMETHYL-4-ETHYL-PYRROLIUM-2-YLIDENE)-CYCLOBUTEN-2-ONE-4-OLATE
O-[BIS(4-METHOXYPHENYL)PHOSPHINYL]-N-(TERT-BUTOXYCARBONYL)HYDROXYLAMINE
C19H24NO6P (393.13411740000004)
3-(7-CYANO-5-(2-NITROPROPYL)INDOLIN-1-YL)PROPYL BENZOATE
C22H23N3O4 (393.16884780000004)
N-(4-Fluoro-2-methoxy-5-nitrophenyl)-4-(1-methyl-1H-indol-3-yl)-2-pyrimidinamine
(E)-2,4,6-triMethoxystyryl-4-Methoxy-3-aminobenzylsulfone, (E)-5-((2,4,6-triMethoxystyrylsulfonyl)Methyl)-2-Methoxybenzeneamine
C19H23NO6S (393.12460180000005)
METHYL 4-(4-METHYL-5-(2-(TRIFLUOROMETHYL)PHENYL)-4H-1,2,4-TRIAZOL-3-YL)BICYCLO[2.2.2]OCTANE-1-CARBOXYLATE
N-HYDROXY-4-(4-METHYL-5-(2-(TRIFLUOROMETHYL)PHENYL)-4H-1,2,4-TRIAZOL-3-YL)BICYCLO[2.2.2]OCTANE-1-CARBOXIMIDAMIDE
Besifloxacin
C19H21ClFN3O3 (393.12553980000007)
D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AE - Fluoroquinolones D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D004791 - Enzyme Inhibitors
BENZYL 5-(BENZYLOXY)-4-METHOXY-2-NITROBENZOATE
C22H19NO6 (393.12123140000006)
BOC-THIONOLEU-1-(6-NITRO)BENZOTRIAZOLIDE
C17H23N5O4S (393.14706780000006)
7-[2-[[(1S,2S)-1-hydroxy-1-phenylpropan-2-yl]amino]ethyl]-1,3-dimethylpurine-2,6-dione,hydrochloride
C18H24ClN5O3 (393.15675840000006)
Nalbuphine Hydrochloride
C21H28ClNO4 (393.1706758000001)
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D000700 - Analgesics
Fmoc-(R)-3-Amino-3-(2-thienyl)-propionic acid
C22H19NO4S (393.1034734000001)
7-[(3R)-3-isothiocyanatopyrrolidin-1-yl]-N,N-dimethyl-2,1,3-benzoxadiazole-4-sulfonamide
2-(2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethyl)isoindoline-1,3-dione
(2S)-(+)-1-BENZOYL-2-TERT-BUTYL-3-METHYL-4-IMIDAZOLIDINONE
Rimcazole dihydrochloride
Rimcazole (BW 234U) dihydrochloride is a carbazole derivative that acts in part as a sigma (σ) receptor antagonist. Rimcazole dihydrochloride also binds with moderate affinity to the dopamine transporter and inhibit dopamine uptake. Rimcazole dihydrochloride can reduce locomotor activity and sensitization. Rimcazole dihydrochloride also can be used for the research of cancer[1][2][3][4].
2,6-BIS((3AR,8AS)-8,8A-DIHYDRO-3AH-INDENO[1,2-D]OXAZOL-2-YL)PYRIDINE
4,4,4-(1,3,5-Triazine-2,4,6-triyl)tris[benzaldehyde]
C24H15N3O3 (393.11133600000005)
9H-Purine-9-acetic acid, 6-[bis[(1,1-diMethylethoxy)carbonyl]aMino]-
N-Desmethyltamoxifen hydrochloride
C25H28ClNO (393.18593080000005)
4-(4-CBZ-PIPERAZIN-1-YL-METHYL)-2-TRIFLUOROMETHYLANILINE
Testolone
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C242 - Anti-Androgen C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent
4-(3-(4-(1-methyl-1H-pyrazol-5-yl)phenylthio)phenyl)-tetrahydro-2H-pyran-4-carboxamide
PF-4191834 (PF-04191834) is an orally active, noniron chelating, and non-redox inhibitor of the 5-Lipoxygenase (5-LOX) (IC50=229 nM), displays ~300-fold selectivity for 5-LOX over 12-LOX and 15-LOX, shows no activity toward the cyclooxygenase enzymes, and is effective in inflammation and pain[1].
2-(4-Ethoxyphenyl)-3-[4-(methylsulfonyl)phenyl]pyrazolo[1,5-b]pyridazine
C21H19N3O3S (393.11470640000005)
N-Hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](3-picolyl)amino]-3-methylbutanamide hydrochloride
C18H23N3O5S (393.13583480000005)
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D061965 - Matrix Metalloproteinase Inhibitors
2-(Biphenyl-4-sulfonyl)-1,2,3,4-tetrahydro-isoquinoline-3-carboxylic acid
C22H19NO4S (393.1034734000001)
4-({(2E,6R)-6-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]hept-2-enoyl}amino)benzoic acid
C20H27NO7 (393.17874320000004)
2-fluoro-N-[4-[4-[2-furanyl(oxo)methyl]-1-piperazinyl]phenyl]benzamide
C22H20FN3O3 (393.14886220000005)
4-{2-[(4-fluorophenyl)sulfonyl]acetyl}-2,6-dimethylphenyl N,N-dimethylcarbamate
C19H20FNO5S (393.10461620000007)
L-seryl-L-tyrosine 2-naphthylamide
C22H23N3O4 (393.16884780000004)
N-[2-(2,4-dimethylphenyl)-4,6-dihydrothieno[3,4-c]pyrazol-3-yl]-1,3-benzodioxole-5-carboxamide
C21H19N3O3S (393.11470640000005)
2-(4-chlorophenyl)-8-methylimidazo[1,2-a]pyridine-3-carbaldehyde O-(3-fluorobenzyl)oxime
2-(4-chlorophenyl)-7-methylimidazo[1,2-a]pyridine-3-carbaldehyde O-(3-fluorobenzyl)oxime
1-(3,4-dihydro-2H-quinolin-1-yl)-2-[[1-(4-ethoxyphenyl)-2-imidazolyl]thio]ethanone
Rel-(9R,12S)-9,10,11,12-tetrahydro-9,12-epoxy-1H-diindolo[1,2,3-FG:3,2,1-KL]pyrrolo[3,4-I][1,6]benzodiazocine-1,3(2H)-dione
C24H15N3O3 (393.11133600000005)
5-{[4-(9H-Fluoren-9-YL)piperazin-1-YL]carbonyl}-1H-indole
2-({8-[(3R)-3-Aminopiperidin-1-YL]-1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-YL}methyl)benzonitrile
N-cyclopropyl-4-methyl-3-[1-(2-methylphenyl)phthalazin-6-yl]benzamide
5-Fluoro-1-[4-(4-phenyl-3,6-dihydropyridin-1(2H)-YL)butyl]quinazoline-2,4(1H,3H)-dione
Daprodustat
B - Blood and blood forming organs > B03 - Antianemic preparations C78275 - Agent Affecting Blood or Body Fluid Daprodustat (GSK1278863) is an orally active hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor being developed for the treatment of anemia associated with chronic kidney disease.
N-{3-[(3-methoxyphenyl)carbamoyl]-5,6-dihydro-4H-cyclopenta[b]thiophen-2-yl}pyridine-3-carboxamide
C21H19N3O3S (393.11470640000005)
5-methyl-4-oxo-2-(2-oxopropyl)-8-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-7-olate
C19H21O9- (393.11855160000005)
2-((6-O-(beta-D-apiofuranosyl)beta-D-glucopyranosyl)oxy)-2-methylbutanenitrile
C16H27NO10 (393.16348819999996)
3-[(2E,4E,6E)-6,8-dimethyldeca-2,4,6-trienoyl]-1-hydroxy-5-(4-oxidophenyl)-2-oxopyridin-4-olate
C23H23NO5-2 (393.15761480000003)
2-[[(3R)-3-(4-fluorophenyl)-3-(4-phenylphenoxy)propyl]-methylamino]acetic acid
C24H24FNO3 (393.17401259999997)
Leu-Phe-Asp
A tripeptide composed of L-leucine, L-phenylalanine and L-aspartic acid joined in sequence by peptide linkages.
n-[2-(4-Phenoxybenzyl)benzimidazol-5-yl]methanesulphonamide
C21H19N3O3S (393.11470640000005)
3-[4-(1,3-Benzodioxol-5-ylmethyl)piperazin-1-yl]-1-phenylpyrrolidine-2,5-dione
C22H23N3O4 (393.16884780000004)
N-[4-(4-morpholinyl)phenyl]-5-(2-nitrophenyl)-2-furancarboxamide
C21H19N3O5 (393.13246440000006)
4-[(Z)-[1-(4-cyanophenyl)-5-oxo-3-phenylpyrazol-4-ylidene]methyl]benzoic acid
C24H15N3O3 (393.11133600000005)
2-amino-3-cyano-5-oxo-1-spiro[7,8-dihydro-6H-1-benzopyran-4,4-piperidine]carboxylic acid (phenylmethyl) ester
C22H23N3O4 (393.16884780000004)
Isopropyl 6-methyl-2-[(phenylsulfonyl)amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate
C19H23NO4S2 (393.10684380000004)
3-{[1-(3-Chloro-phenyl)-3-methyl-5-oxo-1,5-dihydro-pyrazol-4-ylidenemethyl]-amino}-2-methyl-3H-quinazolin-4-one
1-[4-(4-Phenylmethoxyphenyl)-2-thiazolyl]-4-piperidinecarboxamide
N-(3-imidazol-1-ylpropyl)-2-[(4-nitrobenzoyl)amino]benzamide
C20H19N5O4 (393.14369740000006)
2-(3,4-Dimethoxyphenyl)-4-quinolinecarboxylic acid (2-oxo-3-oxolanyl) ester
C22H19NO6 (393.12123140000006)
2-[1-[[[(4-Methoxyphenyl)-oxomethyl]amino]-sulfanylidenemethyl]-3-oxo-2-piperazinyl]acetic acid propan-2-yl ester
C18H23N3O5S (393.13583480000005)
N-{(E)-[2,4,6-trioxo-1-(2,4,6-trimethylphenyl)tetrahydropyrimidin-5(2H)-ylidene]methyl}pyridine-4-carbohydrazide
C20H19N5O4 (393.14369740000006)
[1-[2-(2-Methylphenoxy)ethyl]-3-indolyl]-(4-methyl-1-piperazinyl)methanethione
C23H27N3OS (393.18747320000006)
11-(3-methoxypropyl)-3-((tetrahydrofuran-2-yl)methyl)-3H-pyrimido[5,4:4,5]pyrrolo[2,3-b]quinoxalin-4(11H)-one
C21H23N5O3 (393.18008080000004)
5-Ethyl-2-[[oxo-(3,4,5-trimethoxyphenyl)methyl]amino]-3-thiophenecarboxylic acid ethyl ester
C19H23NO6S (393.12460180000005)
2,5-Dimethyl-3-furancarboxylic acid [2-(2-ethoxyanilino)-2-oxo-1-phenylethyl] ester
C23H23NO5 (393.15761480000003)
8-Methoxy-6-nitro-3-[oxo-(2-phenyl-4,5-dihydroimidazol-1-yl)methyl]-1-benzopyran-2-one
2-[4-(2-methoxyphenyl)-1-piperazinyl]-N-[4-(1-tetrazolyl)phenyl]acetamide
2-[(3-cyano-4-phenyl-6-thiophen-2-yl-2-pyridinyl)thio]-N-propan-2-ylacetamide
C21H19N3OS2 (393.09694840000003)
N-[2,5-diethoxy-4-[[ethylamino(sulfanylidene)methyl]amino]phenyl]-2-thiophenecarboxamide
2-[5-(2-Aminophenyl)-2-tetrazolyl]-1-[4-(4-methoxyphenyl)-1-piperazinyl]ethanone
(3E)-3-{2-[(4-methoxyphenyl)carbonyl]hydrazinylidene}-N-[3-(trifluoromethyl)phenyl]butanamide
C19H18F3N3O3 (393.13001940000004)
(15R)-13-[(2-Chlorophenyl)methyl]-10,10-dimethyl-8,11,13-triazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(9),2,4,6-tetraene-12,14-dione
C22H20ClN3O2 (393.12439700000004)
Glu-Phe-Val
A tripeptide composed of L-glutamic acid, L-phenylalanine and L-valine joined in sequence by peptide linkages.
[(1S,2aR,8bR)-1-(hydroxymethyl)-2-(4-oxazolylmethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-(3-fluorophenyl)methanone
C22H20FN3O3 (393.14886220000005)
(3E)-1-[3-(dimethylamino)propyl]-5-fluoro-3-[(5-methoxy-1H-indol-3-yl)methylidene]indol-2-one
(2S,3R,4S)-1-(5-ethyl-2-thiazolyl)-3-[4-(3-fluorophenyl)phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
C22H20FN3OS (393.13110420000004)
(2S,3S,4S)-1-(5-ethyl-2-thiazolyl)-3-[4-(3-fluorophenyl)phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
C22H20FN3OS (393.13110420000004)
(2S,3S,4R)-1-(5-ethyl-2-thiazolyl)-3-[4-(3-fluorophenyl)phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
C22H20FN3OS (393.13110420000004)
3-fluoro-N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3-oxanyl]benzamide
C18H20FN3O4S (393.11584920000007)
3-fluoro-N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3-oxanyl]benzamide
C18H20FN3O4S (393.11584920000007)
1-(4-fluorophenyl)-3-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-(4-morpholinyl)-2-oxoethyl]-3,6-dihydro-2H-pyran-3-yl]urea
1-(4-fluorophenyl)-3-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-(4-morpholinyl)-2-oxoethyl]-3,6-dihydro-2H-pyran-3-yl]urea
(2R,3R,4R)-1-(5-ethyl-2-thiazolyl)-3-[4-(3-fluorophenyl)phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
C22H20FN3OS (393.13110420000004)
(2R,3S,4S)-1-(5-ethyl-2-thiazolyl)-3-[4-(3-fluorophenyl)phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
C22H20FN3OS (393.13110420000004)
(2R,3S,4R)-1-(5-ethyl-2-thiazolyl)-3-[4-(3-fluorophenyl)phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
C22H20FN3OS (393.13110420000004)
4-[4-[(1S,5R)-3-(1-oxo-2-phenylethyl)-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]benzonitrile
[(1S)-1-ethylsulfonyl-7-methoxy-2,9-dimethyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]methanol
C19H27N3O4S (393.17221820000003)
N-[(E)-[5-(2-nitrophenyl)furan-2-yl]methylideneamino]-2,3-dihydro-1,4-benzodioxine-3-carboxamide
3-fluoro-N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3-oxanyl]benzamide
C18H20FN3O4S (393.11584920000007)
3-fluoro-N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3-oxanyl]benzamide
C18H20FN3O4S (393.11584920000007)
3-fluoro-N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3-oxanyl]benzamide
C18H20FN3O4S (393.11584920000007)
3-fluoro-N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3-oxanyl]benzamide
C18H20FN3O4S (393.11584920000007)
1-(4-fluorophenyl)-3-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-(4-morpholinyl)-2-oxoethyl]-3,6-dihydro-2H-pyran-3-yl]urea
1-(4-fluorophenyl)-3-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-(4-morpholinyl)-2-oxoethyl]-3,6-dihydro-2H-pyran-3-yl]urea
(2S,3R,4R)-1-(5-ethyl-2-thiazolyl)-3-[4-(3-fluorophenyl)phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
C22H20FN3OS (393.13110420000004)
[(1R,2aS,8bS)-1-(hydroxymethyl)-2-(4-oxazolylmethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-(3-fluorophenyl)methanone
C22H20FN3O3 (393.14886220000005)
[(1R)-1-ethylsulfonyl-7-methoxy-1-spiro[1,2,3,9-tetrahydropyrido[3,4-b]indole-4,4-piperidine]yl]methanol
C19H27N3O4S (393.17221820000003)
[(1R)-1-ethylsulfonyl-7-methoxy-2,9-dimethyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]methanol
C19H27N3O4S (393.17221820000003)
2-[(2,5-dimethylphenyl)thio]acetic acid [3-(1H-benzimidazol-2-yl)-3-cyano-2-oxopropyl] ester
C21H19N3O3S (393.11470640000005)
5-[[4-[(Z)-2-cyano-2-(4-fluorophenyl)ethenyl]-2-methoxyphenoxy]methyl]furan-2-carboxylic acid
Cyclohexyl 2-methyl-4-thiophen-2-yl-3,4-dihydropyrimido[1,2-a]benzimidazole-3-carboxylate
(2,5-Dioxopyrrolidin-1-yl) 4-(3,6-diaminoacridin-10-ium-10-yl)butanoate
2-chloro-4-[[(1R)-1-[5-(4-cyanophenyl)-1,3,4-oxadiazol-2-yl]-2-hydroxypropyl]amino]-3-methylbenzonitrile
Erlotinib
C22H23N3O4 (393.16884780000004)
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EB - Epidermal growth factor receptor (egfr) tyrosine kinase inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents
Tifluadom
C22H20FN3OS (393.13110420000004)
C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D045283 - Natriuretic Agents > D004232 - Diuretics Same as: D02694
GR113808
C19H27N3O4S (393.17221820000003)
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists GR 113808 is a potent and highly selective 5-HT4?receptor antagonist (pKb= 8.8). GR 113808 shows 300-fold selectivity over 5-HT1A, 5-HT1B, 5-HT2A, 5-HT2C and 5-HT3 receptors[1].
Agomelatine (L(+)-Tartaric acid)
Agomelatine L(+)-Tartaric acid (S-20098 L(+)-Tartaric acid) is a specific agonist of MT1 and MT2 receptors with Kis of 0.1, 0.06, 0.12, and 0.27 nM for CHO-hMT1, HEK-hMT1, CHO-hMT2, and HEK-hMT2, respectively[1]. Agomelatine L(+)-Tartaric acid is a selective 5-HT2C receptor antagonist with pKis of 6.4 and 6.2 at native (porcine) and cloned, human 5-HT2C receptors, respectively[2].
AKT Kinase Inhibitor (hydrochloride)
AKT Kinase Inhibitor hydrochloride is an Akt kinase inhibitor with anti-tumor activity[1]. AKT Kinase Inhibitor (hydrochloride) is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
CJ-13,610
CJ-13,610, a nonredox-type 5-LO inhibitor, dose dependently suppresses 5-LO product formation in ionophore A23187-stimulated PMNL in the absence of exogenous AA with an IC50 of about 70 nM[1]. PMNL: polymorphonuclear leukocytes; AA: arachidonic acid
SCD1 inhibitor-3
C19H16FN7O2 (393.13494479999997)
SCD1 inhibitor-3 is a safe, potent and orally active SCD1 inhibitor. SCD1 inhibitor-3 can be used for the research of metabolic diseases such as obesity, type II diabetes and dyslipidemia, as well as skin diseases, acne and cancer[1].
1-[(6s)-2,3-dihydroxy-7,8-dimethoxy-5-methyl-6h-benzo[c]phenanthridin-6-yl]propan-2-one
C23H23NO5 (393.15761480000003)
(2s)-20-hydroxy-10,18-dimethoxy-6,14,22-triazapentacyclo[12.8.0.0²,⁶.0⁸,¹³.0¹⁶,²¹]docosa-1(22),8,10,12,16,18,20-heptaene-7,15-dione
C21H19N3O5 (393.13246440000006)
{7-[(2-methylbut-2-enoyl)oxy]-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl}methyl 3-hydroxy-2,4-dimethyl-5-oxooxolane-3-carboxylate
C20H27NO7 (393.17874320000004)
7-benzyl-6,10-dihydroxy-4-(sec-butyl)-15-oxa-2,5,8-triazatricyclo[8.5.0.0³,⁸]pentadeca-1,3,5,11,13-pentaen-9-one
C22H23N3O4 (393.16884780000004)
10,19-dimethoxy-7,15-dioxo-6,14,22λ⁵-triazapentacyclo[12.8.0.0²,⁶.0⁸,¹³.0¹⁷,²²]docosa-1(22),8,10,12,16,18,20-heptaen-22-ylium-16-olate
C21H19N3O5 (393.13246440000006)
5-ethanimidoyl-4,18-dihydroxy-8,8,16-trimethyl-7,16-diazapentacyclo[9.7.1.0²,⁹.0³,⁷.0¹⁵,¹⁹]nonadeca-1(18),4,11(19),12,14-pentaene-6,17-dione
C22H23N3O4 (393.16884780000004)
20-ethoxy-17,18-dimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14(19),15,17-octaene
C23H23NO5 (393.15761480000003)
2-[(2s)-2-[(1r)-1-carboxyethyl]-4-hydroxy-7-oxo-2h,3h,5h-furo[2,3-f]isoindol-6-yl]pentanedioic acid
C18H19NO9 (393.10597640000003)
(1s)-1-[(20s)-17,18-dimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14,16,18-octaen-20-yl]ethanol
C23H23NO5 (393.15761480000003)
(2s)-2-{[(2s)-2-{[(2s)-2-amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxy-3-phenylpropylidene]amino}butanedioic acid
(1r,7r,7ar)-7-({[(2r,3r)-2,3-dihydroxy-2-methylbutanoyl]oxy}methyl)-hexahydro-1h-pyrrolizin-1-yl 2-hydroxybenzoate
C20H27NO7 (393.17874320000004)
(7s,10r)-7-benzyl-4-[(2r)-butan-2-yl]-6,10-dihydroxy-15-oxa-2,5,8-triazatricyclo[8.5.0.0³,⁸]pentadeca-1,3,5,11,13-pentaen-9-one
C22H23N3O4 (393.16884780000004)
[(7r)-7-{[(2z)-2-methylbut-2-enoyl]oxy}-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2s,3r,4r)-3-hydroxy-2,4-dimethyl-5-oxooxolane-3-carboxylate
C20H27NO7 (393.17874320000004)
2-[2-(1-carboxyethyl)-4-hydroxy-7-oxo-2h,3h,5h-furo[2,3-f]isoindol-6-yl]pentanedioic acid
C18H19NO9 (393.10597640000003)
[(7s,7ar)-7-{[(2e)-2-methylbut-2-enoyl]oxy}-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2r,3r,4s)-3-hydroxy-2,4-dimethyl-5-oxooxolane-3-carboxylate
C20H27NO7 (393.17874320000004)
[(7r)-7-{[(2z)-2-methylbut-2-enoyl]oxy}-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2r,3s,4s)-3-hydroxy-2,4-dimethyl-5-oxooxolane-3-carboxylate
C20H27NO7 (393.17874320000004)
(2r,3s,9r)-5-ethanimidoyl-4,18-dihydroxy-8,8,16-trimethyl-7,16-diazapentacyclo[9.7.1.0²,⁹.0³,⁷.0¹⁵,¹⁹]nonadeca-1(18),4,11(19),12,14-pentaene-6,17-dione
C22H23N3O4 (393.16884780000004)
(4s,7s)-7-benzyl-4,6-dihydroxy-4-(sec-butyl)-15-oxa-2,5,8-triazatricyclo[8.5.0.0³,⁸]pentadeca-1(10),2,5,11,13-pentaen-9-one
C22H23N3O4 (393.16884780000004)
(4s,7s)-7-benzyl-6-hydroxy-4-isopropyl-4-methoxy-15-oxa-2,5,8-triazatricyclo[8.5.0.0³,⁸]pentadeca-1(10),2,5,11,13-pentaen-9-one
C22H23N3O4 (393.16884780000004)
2-hydroxy-6-methoxy-6'-(2-methylprop-1-en-1-yl)-1',7'-diazaspiro[indole-3,5'-tricyclo[7.3.0.0³,⁷]dodecan]-3'-ene-2',8'-dione
C22H23N3O4 (393.16884780000004)
(1s,12s,13r)-12-hydroxy-5-methoxy-12-(2-methoxyphenyl)-6-methyl-16-oxa-7-azatetracyclo[11.2.1.0²,¹¹.0³,⁸]hexadeca-2,5,8,10-tetraen-4-one
C23H23NO5 (393.15761480000003)
(1r,12s,13s)-12-hydroxy-5-methoxy-12-(2-methoxyphenyl)-6-methyl-16-oxa-7-azatetracyclo[11.2.1.0²,¹¹.0³,⁸]hexadeca-2,5,8,10-tetraen-4-one
C23H23NO5 (393.15761480000003)
(1r,3s,5s,6s,7s)-6,7-dihydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl (2e)-3-(3,4,5-trimethoxyphenyl)prop-2-enoate
C20H27NO7 (393.17874320000004)
7-acetyl-6,19-dihydroxy-10,15,15-trimethyl-16-oxa-10-azatetracyclo[9.8.0.0³,⁹.0¹²,¹⁷]nonadeca-1(19),3(9),4,6,11,13,17-heptaene-2,8-dione
C22H19NO6 (393.12123140000006)
20-hydroxy-10,18-dimethoxy-6,14,22-triazapentacyclo[12.8.0.0²,⁶.0⁸,¹³.0¹⁶,²¹]docosa-1(22),8,10,12,16,18,20-heptaene-7,15-dione
C21H19N3O5 (393.13246440000006)
2-hydroxy-7-(1-hydroxyethylidene)-10,15,15-trimethyl-16-oxa-10-azatetracyclo[9.8.0.0³,⁹.0¹²,¹⁷]nonadeca-1,3(9),4,11,13,17-hexaene-6,8,19-trione
C22H19NO6 (393.12123140000006)
(1r,3r,5s,6r)-6-(acetyloxy)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3,4,5-trimethoxybenzoate
C20H27NO7 (393.17874320000004)
(1s,12r,13r)-12-hydroxy-5-methoxy-12-(2-methoxyphenyl)-6-methyl-16-oxa-7-azatetracyclo[11.2.1.0²,¹¹.0³,⁸]hexadeca-2,5,8,10-tetraen-4-one
C23H23NO5 (393.15761480000003)
{4-ethylidene-7-hydroxy-7-methyl-3,8-dioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-en-6-yl}methyl acetate
C20H27NO7 (393.17874320000004)
(2s)-2-{[(4s)-4-amino-4-carboxy-1-hydroxybutylidene]amino}-4-{[(1r)-1-carboxy-2-(methylsulfanyl)ethyl]-c-hydroxycarbonimidoyl}butanoic acid
C14H23N3O8S (393.12057980000003)
(7s,10s)-7-benzyl-6,10-dihydroxy-4-(sec-butyl)-15-oxa-2,5,8-triazatricyclo[8.5.0.0³,⁸]pentadeca-1,3,5,11,13-pentaen-9-one
C22H23N3O4 (393.16884780000004)
[(7r,7ar)-7-{[(2z)-2-methylbut-2-enoyl]oxy}-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2s,3r,4r)-3-hydroxy-2,4-dimethyl-5-oxooxolane-3-carboxylate
C20H27NO7 (393.17874320000004)
2-imino-6,7-dimethoxy-4-(4-methoxyphenyl)-1-methyl-3h-naphtho[2,3-d]imidazole-5,8-dione
C21H19N3O5 (393.13246440000006)
2-{[(2s,3r,4s,5s,6s)-6-{[(2s,3s)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl](hydroxy)methyl}-3,4,5-trihydroxyoxan-2-yl]oxy}-2-methylbutanenitrile
C16H27NO10 (393.16348819999996)
(1r,7r,7ar)-7-({[(2s,3r)-2,3-dihydroxy-2-methylbutanoyl]oxy}methyl)-hexahydro-1h-pyrrolizin-1-yl 2-hydroxybenzoate
C20H27NO7 (393.17874320000004)
2-[(1r,3s,4ar,10ar)-4a,9,10a-trihydroxy-7-methoxy-5,10-dioxo-1-propyl-1h,3h,4h-naphtho[2,3-c]pyran-3-yl]ethanimidic acid
(2z,6z,8s,11s,13e)-11-hydroxy-15-(2-hydroxy-1,3-thiazol-4-yl)-3,8-dimethyl-15-oxopentadeca-2,6,13-trienoic acid
C20H27NO5S (393.1609852000001)
2-amino-4-[(1-carboxy-3-{[1-carboxy-2-(methylsulfanyl)ethyl]-c-hydroxycarbonimidoyl}propyl)-c-hydroxycarbonimidoyl]butanoic acid
C14H23N3O8S (393.12057980000003)
5-methoxy-4,7-bis(4-methoxyphenyl)-1,3-benzothiazol-6-ol
C22H19NO4S (393.1034734000001)
[(1r,4z,6s,7s,17s)-4-ethylidene-7-hydroxy-7-methyl-3,8-dioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-en-6-yl]methyl acetate
C20H27NO7 (393.17874320000004)
10,18-dimethoxy-21-oxa-6,14,23-triazapentacyclo[12.9.0.0²,⁶.0⁸,¹³.0¹⁶,²²]tricosa-1(23),8,10,12,16(22),17,19-heptaene-7,15-dione
C21H19N3O5 (393.13246440000006)
7-benzyl-4,6-dihydroxy-4-(sec-butyl)-15-oxa-2,5,8-triazatricyclo[8.5.0.0³,⁸]pentadeca-1(10),2,5,11,13-pentaen-9-one
C22H23N3O4 (393.16884780000004)
7-benzyl-6-hydroxy-4-isopropyl-4-methoxy-15-oxa-2,5,8-triazatricyclo[8.5.0.0³,⁸]pentadeca-1(10),2,5,11,13-pentaen-9-one
C22H23N3O4 (393.16884780000004)
(7s,10r)-7-benzyl-6-hydroxy-4-isopropyl-10-methoxy-15-oxa-2,5,8-triazatricyclo[8.5.0.0³,⁸]pentadeca-1,3,5,11,13-pentaen-9-one
C22H23N3O4 (393.16884780000004)
(3s,6's,9's)-2-hydroxy-6-methoxy-6'-(2-methylprop-1-en-1-yl)-1',7'-diazaspiro[indole-3,5'-tricyclo[7.3.0.0³,⁷]dodecan]-3'-ene-2',8'-dione
C22H23N3O4 (393.16884780000004)
[(7r,7ar)-7-{[(2z)-2-methylbut-2-enoyl]oxy}-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2s,3r,4s)-3-hydroxy-2,4-dimethyl-5-oxooxolane-3-carboxylate
C20H27NO7 (393.17874320000004)
7-benzyl-6-hydroxy-4-isopropyl-10-methoxy-15-oxa-2,5,8-triazatricyclo[8.5.0.0³,⁸]pentadeca-1,3,5,11,13-pentaen-9-one
C22H23N3O4 (393.16884780000004)
(21r)-5,10,11-trimethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11,19-octaene-6,21-diol
C23H23NO5 (393.15761480000003)
(2r)-2-[(2r)-2-[(1r)-1-carboxyethyl]-4-hydroxy-7-oxo-2h,3h,5h-furo[2,3-f]isoindol-6-yl]pentanedioic acid
C18H19NO9 (393.10597640000003)
13-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-1(24),2,4(8),9,14(22),15,17(21)-heptaen-12-yl acetate
C22H19NO6 (393.12123140000006)
[(1r,4e,6s,7s,17s)-4-ethylidene-7-hydroxy-7-methyl-3,8-dioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-en-6-yl]methyl acetate
C20H27NO7 (393.17874320000004)
n-{2-[12-methoxy-11-(methylsulfanyl)-8,14-diazatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,9,11,13,15-octaen-10-yl]ethyl}propanimidic acid
1-{17,18-dimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14,16,18-octaen-20-yl}ethanol
C23H23NO5 (393.15761480000003)
7-{[(2,3-dihydroxy-2-methylbutanoyl)oxy]methyl}-hexahydro-1h-pyrrolizin-1-yl 2-hydroxybenzoate
C20H27NO7 (393.17874320000004)
5,10,11-trimethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11,19-octaene-6,21-diol
C23H23NO5 (393.15761480000003)
5,6,7-trimethoxy-4-(4-methoxyphenyl)-1-methyl-3h-naphtho[2,3-d]imidazol-2-imine
C22H23N3O4 (393.16884780000004)
(7s,10s)-7-benzyl-4-[(2r)-butan-2-yl]-6,10-dihydroxy-15-oxa-2,5,8-triazatricyclo[8.5.0.0³,⁸]pentadeca-1,3,5,11,13-pentaen-9-one
C22H23N3O4 (393.16884780000004)